Xiangbin Wan
Impact in
-
- Cancer-related molecular mechanisms research
-
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- Gastric Cancer Management and Outcomes 6
- Metastasis and carcinoma case studies 2
-
- DNA Repair Mechanisms 2
- Epigenetics and DNA Methylation 2
- PI3K/AKT/mTOR signaling in cancer 2
- Co-authors
- Yingjun Liu (4 shared papers)Guangsen Han (4 shared papers)Gangcheng Wang (4 shared papers)Yuzhou Zhao (3 shared papers)Yong Cheng (3 shared papers)Wenying Deng (5 shared papers)Yaqi Zhang (1 shared paper)Yi Li (1 shared paper)
- Journals
- Journal of Clinical Oncology (7 papers)Medical Oncology (2 papers)Signal Transduction and Targeted Therapy (1 paper)Journal of Surgical Oncology (1 paper)Journal of Cellular Biochemistry (1 paper)
- Partner nations
- ChinaUnited StatesNorway
In The Last Decade
Xiangbin Wan
24 papers receiving 331 citations
Peers
Comparison fields: 5 of 49
- Cancer Research 87
- Hepatology 34
- Gastroenterology 22
- Oncology 88
- Pulmonary and Respiratory Medicine 64
Countries citing papers authored by Xiangbin Wan
This map shows the geographic impact of Xiangbin Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangbin Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangbin Wan more than expected).
Fields of papers citing papers by Xiangbin Wan
This network shows the impact of papers produced by Xiangbin Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangbin Wan. The network helps show where Xiangbin Wan may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiangbin Wan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Association of long non-coding RNA HOTTIP with progression and prognosis in colorectal cancer. | 2015 | 54 |
| 2 | 2012 | 40 | |
| 3 | 2009 | 39 | |
| 4 | 2013 | 34 | |
| 5 | 2019 | 33 | |
| 6 | 2019 | 30 | |
| 7 | 2024 | 15 | |
| 8 | 2018 | 13 | |
| 9 | 2015 | 11 | |
| 10 | 2021 | 10 | |
| 11 | 2024 | 9 | |
| 12 | 2024 | 9 | |
| 13 | 2008 | 8 | |
| 14 | 2022 | 7 | |
| 15 | 2022 | 4 | |
| 16 | 2014 | 4 | |
| 17 | 2024 | 4 | |
| 18 | 2017 | 4 | |
| 19 | 2023 | 3 | |
| 20 | [Relationship of preoperative and postoperative myeloid-derived suppressor cells percentage with the prognosis in rectal cancer patients]. | 2015 | 2 |
About Xiangbin Wan
Xiangbin Wan is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Gastroenterology and Surgery, having authored 25 papers that have together received 337 indexed citations. Recurring topics across this work include Gastrointestinal Tumor Research and Treatment (6 papers), Gastric Cancer Management and Outcomes (6 papers), DNA Repair Mechanisms (2 papers), Esophageal Cancer Research and Treatment (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Epigenetics and DNA Methylation (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and Metastasis and carcinoma case studies (2 papers). The work is most often cited by research in Cancer Research (87 citations), Hepatology (34 citations), Gastroenterology (22 citations), Oncology (88 citations) and Pulmonary and Respiratory Medicine (64 citations). Xiangbin Wan has collaborated with scholars based in China, United States and Norway. Frequent co-authors include Yingjun Liu, Guangsen Han, Gangcheng Wang, Yuzhou Zhao, Yong Cheng, Wenying Deng, Yaqi Zhang, Yi Li, Shengping Li and Yunfei Yuan. Their work appears in journals such as Journal of Clinical Oncology, Medical Oncology, Signal Transduction and Targeted Therapy, Journal of Surgical Oncology and Journal of Cellular Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.